Skip to main content

MK-3682 PN011 A Phase II, Randomized, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regime of MK-5172 with Either MK-8742 or MK-8408 in Subjects with Chronic HCV GT1, GT2 and GT4 Infection "C-CREST 1"

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Gastroenterology

Awarded By

Merck Sharp & Dohme

Start Date

February 1, 2015

End Date

December 1, 2017
 

Administered By

Medicine, Gastroenterology

Awarded By

Merck Sharp & Dohme

Start Date

February 1, 2015

End Date

December 1, 2017